Marketing-authorisation holder · United States
Dexcel
6 medicines in 1 country, as authorisation holder.
Group structure
Part of
DexcelPharmaceutical groupOther companies in the group
Singapore2
United Kingdom1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DICLOFENAC SODIUM100mg · Tablet, extended release | Diclofenac | United States | Marketed | 2000 |
| ESOMEPRAZOLE MAGNESIUM20mg base · Tablet, orally disintegrating, delayed release | Esomeprazole | United States | Not marketed | 2020 |
| HEMADY20mg · Tablet | Dexamethasone | United States | Marketed | 2019 |
| OMEPRAZOLE20mg · Tablet, orally disintegrating, delayed release | Omeprazole | United States | Marketed | 2017 |
| OMEPRAZOLE MAGNESIUM20mg base · Capsule, delayed release | Omeprazole | United States | Marketed | 2009 |
| PERIOCHIP2.5mg · Tablet | Chlorhexidine | United States | Not marketed | 1998 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 6 | 6 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- dexcel ltd
- dexcel pharma
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Group
- Dexcel
- Headquarters
- United States
- Medicines
- 6
- Countries
- 1
- Roles
- Authorisation holder